NCL Technology Ventures

NCL Technology Ventures operates as the venture-capital arm of the Nanda family's C&C Alpha Group, the conglomerate through which the family holds interests in healthcare, aviation, and hospitality. C&C Alpha provides the operational backbone and deal-sourcing network, while NCL Technology Ventures manages the early-stage technology portfolio. The two entities share principal ownership but maintain separate investment committees and governance structures.

The firm primarily invests at Seed and Series A stages, occasionally participating in later follow-on rounds for portfolio companies. NCL Technology Ventures focuses on technology companies with initial commercial traction, typically those entering the UK or Indian markets. The firm's stage preference reflects the Nanda family's strategy of combining venture capital with hands-on operational support from C&C Alpha's existing businesses.

No. NCL Technology Ventures invests in both UK-based and Indian technology companies, with a particular interest in startups that can scale across these two markets. The firm's cross-border mandate targets enterprise software, healthtech, and fintech companies seeking regulatory or distribution pathways between Europe and South Asia.

The firm sources deal flow primarily through the Nanda family's extended network of operating companies, industry partnerships, and relationships with other India-focused family offices. C&C Alpha Group's healthcare and hospitality businesses generate proprietary exposure to technology vendors and digital-health startups, creating an inbound pipeline that independent venture funds typically cannot replicate.

Yes. The Nanda family operates philanthropic initiatives focused on rural healthcare delivery and education in India, but these operate as legally distinct entities from NCL Technology Ventures and C&C Alpha Group. The foundation structure ensures that charitable activities remain separated from the family's for-profit technology and industrial investments.